您好,欢迎访问江苏省农业科学院 机构知识库!

Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge

文献类型: 外文期刊

作者: Xu, Xiaohong 1 ; Qian, Jing 3 ; Qin, Lingsong 1 ; Li, Jindou 1 ; Xue, Cong 4 ; Ding, Jiaxin 1 ; Wang, Weiqi 1 ; Ding, Wei 1 ;

作者机构: 1.Jilin Univ, Coll Vet Med, Lab Infect Dis, Key Lab Zoonosis Res,Minist Educ, Changchun 130062, Peoples R China

2.Jilin Univ, Coll Basic Med Sci, Changchun 130021, Peoples R China

3.Minist Agr, Key Lab Vet Bioprod Engn, Inst Vet Med, Jiangsu Acad Agr Sci, Nanjing 210014, Peoples R China

4.Linyi Univ, Coll Agr & Forestry Sci, Linyi 276000, Shandong, Peoples R China

关键词: Newcastle disease virus-like particles; DC-binding peptide; Secretory immunoglobulin A (sIgA); Candidate vaccine

期刊名称:VIROLOGICA SINICA ( 影响因子:4.327; 五年影响因子:4.08 )

ISSN: 1674-0769

年卷期:

页码:

收录情况: SCI

摘要: Newcastle disease virus (NDV) and H9N2 subtype Avian influenza virus (AIV) are two notorious avian respiratory pathogens that cause great losses in the poultry industry. Current inactivated commercial vaccines against NDV and AIV have the disadvantages of inadequate mucosal responses, while an attenuated live vaccine bears the risk of mutation. Dendritic cell (DC) targeting strategies are attractive for their potent mucosal and adaptive immune-stimulating ability against respiratory pathogens. In this study, DC-binding peptide (DCpep)-decorated chimeric virus-like particles (cVLPs), containing NDV haemagglutinin-neuraminidase (HN) and AIV haemagglutinin (HA), were developed as a DC-targeting mucosal vaccine candidate. DCpep-decorated cVLPs activated DCs in vitro, and induced potent immune stimulation in chickens, with enhanced secretory immunoglobulin A (sIgA) secretion and splenic T cell differentiation. 40 mu g cVLPs can provide full protection against the challenge with homologous, heterologous NDV strains, and AIV H9N2. In addition, DCpep-decorated cVLPs could induce a better immune response when administered intranasally than intramuscularly, as indicated by robust sIgA secretion and a reduced virus shedding period. Taken together, this chimeric VLPs are a promising vaccine candidate to control NDV and AIV H9N2 and a useful platform bearing multivalent antigens.

  • 相关文献
作者其他论文 更多>>